Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study - Université de Reims Champagne-Ardenne
Article Dans Une Revue Cancer Année : 2018

Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study

Marie-Amélie Ordan
Camille Mazza
  • Fonction : Auteur
Coralie Barbe
  • Fonction : Auteur
Marine Perrier
Damien Botsen
Yohann Renard
  • Fonction : Auteur
Johanna Moreau
Mathilde Brasseur
  • Fonction : Auteur
Barbara Taillière
  • Fonction : Auteur
Olivier Bouché
  • Fonction : Auteur

Résumé

Handgrip strength (HGS) is a widely studied noninvasive test. Weak strength (dynapenia) seems to be associated with high morbidity and mortality in different populations, notably oncology populations. Despite this, HGS testing is not used in daily practice in oncology. The study was aimed at evaluating the feasibility and acceptability of HGS testing in patients with digestive cancer treated with ambulatory chemotherapy.

Dates et versions

hal-03472804 , version 1 (09-12-2021)

Identifiants

Citer

Marie-Amélie Ordan, Camille Mazza, Coralie Barbe, Marine Perrier, Damien Botsen, et al.. Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study. Cancer, 2018, 124 (7), pp.1501-1506. ⟨10.1002/cncr.31207⟩. ⟨hal-03472804⟩
12 Consultations
0 Téléchargements

Altmetric

Partager

More